This brief summarizes a study on commercial risks and the role of GM-free private standards in biosafety decisionmaking in developing countries. The findings are used to suggest a straightforward decisionmaking framework to help separate real…
Search IFPRI Web
Use quotation marks around a phrase or title for more accurate search results (example: “El Nino”).
This brief analyzes the past successes and recent challenges of South Africa’s trade and marketing policies on genetically modified (GM) products, with the aim of drawing lessons for countries that are designing their biosafety systems.